FNA
Price
$6.25
Change
+$0.19 (+3.14%)
Updated
Nov 5, 04:00 PM (EDT)
7 days until earnings call
GMED
Price
$75.59
Change
+$0.87 (+1.16%)
Updated
Nov 5, 04:00 PM (EDT)
Earnings call today
Ad is loading...

FNA vs GMED

Header iconFNA vs GMED Comparison
Open Charts FNA vs GMEDBanner chart's image
Paragon 28
Price$6.25
Change+$0.19 (+3.14%)
Volume$24.69K
CapitalizationN/A
Globus Medical
Price$75.59
Change+$0.87 (+1.16%)
Volume$133.46K
CapitalizationN/A
View a ticker or compare two or three
FNA vs GMED Comparison Chart
Loading...
FNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GMED
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
FNA vs. GMED commentary
Nov 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNA is a Buy and GMED is a Hold.

COMPARISON
Comparison
Nov 06, 2024
Stock price -- (FNA: $6.06 vs. GMED: $74.72)
Brand notoriety: FNA and GMED are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: FNA: 148% vs. GMED: 112%
Market capitalization -- FNA: $998.19M vs. GMED: $7.19B
FNA [@Medical Specialties] is valued at $998.19M. GMED’s [@Medical Specialties] market capitalization is $7.19B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FNA’s FA Score shows that 0 FA rating(s) are green whileGMED’s FA Score has 1 green FA rating(s).

  • FNA’s FA Score: 0 green, 5 red.
  • GMED’s FA Score: 1 green, 4 red.
According to our system of comparison, GMED is a better buy in the long-term than FNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FNA’s TA Score shows that 4 TA indicator(s) are bullish while GMED’s TA Score has 6 bullish TA indicator(s).

  • FNA’s TA Score: 4 bullish, 4 bearish.
  • GMED’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, GMED is a better buy in the short-term than FNA.

Price Growth

FNA (@Medical Specialties) experienced а +25.21% price change this week, while GMED (@Medical Specialties) price change was +0.70% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.69%. For the same industry, the average monthly price growth was -0.14%, and the average quarterly price growth was -1.28%.

Reported Earning Dates

FNA is expected to report earnings on Feb 27, 2025.

GMED is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Medical Specialties (+0.69% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GMED($7.19B) has a higher market cap than FNA($998M). FNA has higher P/E ratio than GMED: FNA (370.37) vs GMED (49.65). GMED YTD gains are higher at: 40.214 vs. FNA (-51.247). GMED has higher annual earnings (EBITDA): 347M vs. FNA (-26.92M). GMED has more cash in the bank: 518M vs. FNA (75.6M). FNA has less debt than GMED: FNA (110M) vs GMED (520M). GMED has higher revenues than FNA: GMED (1.57B) vs FNA (216M).
FNAGMEDFNA / GMED
Capitalization998M7.19B14%
EBITDA-26.92M347M-8%
Gain YTD-51.24740.214-127%
P/E Ratio370.3749.65746%
Revenue216M1.57B14%
Total Cash75.6M518M15%
Total Debt110M520M21%
FUNDAMENTALS RATINGS
GMED: Fundamental Ratings
GMED
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
49
SMR RATING
1..100
88
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FNAGMED
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
62%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 7 days ago
67%
Declines
ODDS (%)
Bearish Trend 13 days ago
81%
Bearish Trend 12 days ago
58%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
59%
View a ticker or compare two or three
Ad is loading...
FNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GMED
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EMGF48.370.16
+0.34%
iShares Em Mkts Eq Fac ETF
ISMD37.090.03
+0.08%
Inspire Small/Mid Cap ETF
SRLN41.62-0.01
-0.02%
SPDR® Blackstone Senior Loan ETF
XTJL32.83-0.02
-0.07%
Innovator US Equity Acclrtd Pls ETF Jul
PPI15.15-0.04
-0.26%
AXS Astoria Real Assets ETF

GMED and

Correlation & Price change

A.I.dvisor indicates that over the last year, GMED has been loosely correlated with ATEC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if GMED jumps, then ATEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMED
1D Price
Change %
GMED100%
-0.21%
ATEC - GMED
45%
Loosely correlated
+3.08%
MYGN - GMED
43%
Loosely correlated
-0.89%
OFIX - GMED
41%
Loosely correlated
+2.06%
INGN - GMED
34%
Loosely correlated
+3.97%
FNA - GMED
34%
Loosely correlated
+7.83%
More